HopeStage
Back to all studies
CompletedNCT03418623

GET73 and Brain Glutamate Measures in People With Alcohol Use

About this title

Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder

Read the official source — NCT03418623
Medication studyAges 21–40United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 40 years.

Listed locations
CharlestonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 8, 2018
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
Laboratorio Farmaceutico Ct S.r.l.
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 40 Years
Official registry ID
NCT03418623
Official title
Show the full official title

Effect of GET73 on Magnetic Resonance Spectroscopy Measures of Central Glutamate and GABA and Alcohol Cue-elicited Brain Activation in Recently Abstinent Non-treatment Seeking Individuals With Alcohol Use Disorder.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Charleston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Laboratorio Farmaceutico Ct S.r.l.

Did this study involve medication?

Yes. The study involved medication, including GET73.

Who was this study for?

Listed age limits: 21 years to 40 years.

Want to explore more studies?

Explore studies